Michael C. Heinrich, MD

Michael C. Heinrich, MD, is currently Professor of Medicine and Professor of Cell and Developmental Biology at Oregon Health & Science University (OHSU) Knight Cancer Institute in Portland, OR. He is also the head of the OHSU Knight Cancer Institute GIST Translational and Clinical Research Programs. He earned his medical degree in 1984 from Johns Hopkins School of Medicine in Baltimore, MD, and completed both his residency training and fellowship in hematology and medical oncology at OHSU.

Dr Heinrich is recognized internationally for groundbreaking research discoveries that have improved care for patients with gastrointestinal stromal tumors, and his research has implications for many types of cancer. His research revolves around a basic, yet complex, premise. You have to understand what is broken in order to fix it. His primary research interest is in the development of novel tyrosine kinase inhibitors for the treatment of human cancers. His research includes both the preclinical identification of novel molecular targets that cause cancer (which is essential to the development of better and less toxic therapies) and the testing of new agents in the laboratory and the clinic. Additional information on his research program can be found at www.heinrich-corless.net.